Effect of Hepatic Impairment on the Pharmacokinetics of Baicalin in Rats: Critical Roles of Gut Microbiota and Hepatic Transporters
<b>Background</b>: Baicalin (BG) has been used in the treatment of many diseases. However, the effect of hepatic insufficiency on its pharmacokinetics has not been reported, and there is a lack of clinical guidance for the use of BG in patients with hepatic impairment. <b>Methods&l...
Saved in:
| Main Authors: | Ping Li, Yihua Tian, Hong Wang, Yuting Ji, Huiying Zeng, Shengman Zhang, Xiuli Gao, Xiaoyan Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/7/851 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of Bocidelpar, ASP0367, in Renal and Hepatic Impairment: Results From Two Phase 1 Studies
by: Megumi Iwai, et al.
Published: (2025-08-01) -
New Insights Into Hepatic Impairment (HI) Trials
by: Sebastian Haertter, et al.
Published: (2025-01-01) -
Evaluating the Impact of Hepatic or Renal Impairment on Tanimilast (CHF6001) Pharmacokinetics: Two Open‐Label, Parallel‐Group, Single‐Center Studies
by: Annalisa Piccinno, et al.
Published: (2025-05-01) -
Prediction of drug exposure in hepatic impairment: a comparison between minimal physiologically based pharmacokinetic (mPBPK) and whole body PBPK models
by: Iftekhar Mahmood
Published: (2025-02-01) -
Interacting roles of gut microbiota and T cells in the development of autoimmune hepatitis
by: Qingwei Wu, et al.
Published: (2025-05-01)